Neurocrine Biosciences, Inc. (NBIX) financial statements (2021 and earlier)

Company profile

Business Address 12780 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments801671651516307379194
Cash and cash equivalents187112142255837431
Short-term investments614558509261224305163
Receivables1571275631   
Inventory, net of allowances, customer advances and progress billings281711    
Inventory281711    
Other current assets3017208354
Total current assets:1,016831738555310384198
Noncurrent Assets
Operating lease, right-of-use asset8374
Property, plant and equipment45423411633
Long-term investments and receivables227300216247438237
Long-term investments227300216247438237
Restricted cash and investments3355555
Deferred income tax assets319 
Other noncurrent assets3      
Other undisclosed noncurrent assets3856     
Total noncurrent assets:719475255263559145
TOTAL ASSETS:1,7351,306993818365475243
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1691418654262218
Accounts payable  146530
Accrued liabilities  3818211912
Employee-related liabilities38392725  7
Other undisclosed accounts payable and accrued liabilities13110275   
Debt 409     
Deferred revenue and credits 000
Other liabilities181520   
Other undisclosed current liabilities   144(3)
Total current liabilities:1875658854302616
Noncurrent Liabilities
Long-term debt and lease obligation412496388370   
Long-term debt, excluding current maturities318409388370   
Operating lease, liability9487
Liabilities, other than long-term debt1017181312122
Deferred revenue and credits1312122
Deferred rent credit  18
Other liabilities1017  000
Other undisclosed noncurrent liabilities (409)18881217
Total noncurrent liabilities:422104424391202519
Total liabilities:609669512445505034
Stockholders' equity
Stockholders' equity attributable to parent1,126637481372315424209
Common stock0000000
Additional paid in capital1,8501,7681,6601,5731,3711,3411,035
Accumulated other comprehensive income (loss)21(2)(2)(0)(1)(0)
Accumulated deficit(725)(1,133)(1,178)(1,199)(1,056)(915)(826)
Total stockholders' equity:1,126637481372315424209
TOTAL LIABILITIES AND EQUITY:1,7351,306993818365475243

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1,04678845116215203
Revenue, net1621520 
Financial services revenue 333
Cost of revenue
(Cost of Goods and Services Sold)
  (5)(1)   
Gross profit:1,04678844616015203
Operating expenses(883)(716)(414)(293)(162)(114)(64)
Other undisclosed operating income (loss)  51  (3)
Operating income (loss):1637237(131)(147)(94)(64)
Nonoperating income (expense)(56)(26)(15)(11)654
Investment income, nonoperating  16324
Interest and debt expense(18)(32)(31)(20)   
Income (loss) from continuing operations before equity method investments, income taxes:8815(9)(162)(141)(89)(61)
Other undisclosed income from continuing operations before income taxes183231    
Income (loss) from continuing operations before income taxes:1074722(162)(141)(89)(61)
Income tax expense (benefit)301(10)(1)    
Net income (loss):4073721(162)(141)(89)(61)
Other undisclosed net income attributable to parent   20   
Net income (loss) available to common stockholders, diluted:4073721(143)(141)(89)(61)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):4073721(162)(141)(89)(61)
Comprehensive income (loss):4073721(162)(141)(89)(61)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent03(0)181(1)(0)
Comprehensive income (loss), net of tax, attributable to parent:4084021(144)(140)(90)(61)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: